Biotech China Chinese Covid-19 Economy Pandemic Pharmaceutical Technology Vaccine
China National Biotech Group, a subsidiary of pharmaceutical giant Sinopharm, has made unprecedented forays into the global vaccine market amid the COVID-19 pandemic, said Zhang Yuntao, vice-president of the company.
News Timeline:
Track the development of this news story across the Internet.